188 related articles for article (PubMed ID: 3753868)
21. Axenic cultivation of amastigotes of Leishmania donovani and Leishmania major and their infectivity.
al-Bashir NT; Rassam MB; al-Rawi BM
Ann Trop Med Parasitol; 1992 Oct; 86(5):487-502. PubMed ID: 1288430
[TBL] [Abstract][Full Text] [Related]
22. Selective in vitro inhibition of Leishmania donovani by a semi-purified fraction of wild mushroom Grifola frondosa.
Sultana SS; Ghosh J; Chakraborty S; Mukherjee D; Dey S; Mallick S; Dutta A; Paloi S; Khatua S; Dutta T; Bhattacharya S; Acharya K; Ghorai N; Pal C
Exp Parasitol; 2018 Sep; 192():73-84. PubMed ID: 30040961
[TBL] [Abstract][Full Text] [Related]
23. β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. as potential anti-leishmanial agent against leishmania tropica: Docking and molecular insights.
Majid Shah S; Ullah F; Ayaz M; Sadiq A; Hussain S; Ali Shah AU; Adnan Ali Shah S; Wadood A; Nadhman A
Steroids; 2019 Aug; 148():56-62. PubMed ID: 31085212
[TBL] [Abstract][Full Text] [Related]
24. Investigation of in vitro antileishmanial activity of moxifloxacin, linezolid and caspofungin on Leishmania tropica promastigotes.
Limoncu ME; Eraç B; Gürpınar T; Özbilgin A; Balcıoğlu IC; Hoşgör-Limoncu M
Turkiye Parazitol Derg; 2013; 37(1):1-3. PubMed ID: 23619036
[TBL] [Abstract][Full Text] [Related]
25. Effect of fibronectin and interferon-gamma on the uptake of Leishmania major and Leishmania infantum promastigotes by U937 cells.
Savoia D; Biglino S; Cestaro A; Zucca M
Microbiologica; 1992 Jan; 15(1):51-6. PubMed ID: 1556959
[TBL] [Abstract][Full Text] [Related]
26. Two high affinity nucleoside transporters in Leishmania donovani.
Aronow B; Kaur K; McCartan K; Ullman B
Mol Biochem Parasitol; 1987 Jan; 22(1):29-37. PubMed ID: 3807949
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle.
Cooper A; Rosen H; Blackwell JM
Immunology; 1988 Dec; 65(4):511-4. PubMed ID: 3065216
[TBL] [Abstract][Full Text] [Related]
28. Inosine analogs as anti-leishmanial agents.
Rainey P; Nolan PA; Townsend LB; Robins RK; Fox JJ; Secrist Iii JA; Santi DV
Pharm Res; 1985 Sep; 2(5):217-20. PubMed ID: 24272839
[TBL] [Abstract][Full Text] [Related]
29. Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes.
Mosser DM; Handman E
J Leukoc Biol; 1992 Oct; 52(4):369-76. PubMed ID: 1402387
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of Anti-leishmanial Effects of Bee Products (Honey, Propolis) on Leishmania tropica Promastigotes].
Aksoy T; Sivcan E; Doğan F; Çetin S; Yar TM
Mikrobiyol Bul; 2020 Jul; 54(3):479-489. PubMed ID: 32755522
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of in-vitro leishmanicidal activity of hydrazones of thiophene carboxaldehydes against promastigotes of Leishmania infantum and Leishmania tropica.
Savornin B; Madadi NE; Delmas F; Gasquet M; Timon-David P; Vanelle P; Maldonado J
J Pharm Pharmacol; 1991 Jan; 43(1):58-9. PubMed ID: 1676064
[TBL] [Abstract][Full Text] [Related]
32. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
Datta AK; Datta R; Sen B
Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
[TBL] [Abstract][Full Text] [Related]
33. Leishmanicidal activity of stearylamine-bearing liposomes in vitro.
Afrin F; Dey T; Anam K; Ali N
J Parasitol; 2001 Feb; 87(1):188-93. PubMed ID: 11227889
[TBL] [Abstract][Full Text] [Related]
34. Leishmania donovani: in vitro growth inhibition of promastigotes by a carbocyclic analog of 2'-deoxyguanosine.
Dong Z; Zhu B; Jeffrey AM
Exp Parasitol; 1992 Sep; 75(2):257-8. PubMed ID: 1516674
[No Abstract] [Full Text] [Related]
35. Correlation between inhibition of growth and arginine transport of Leishmania donovani promastigotes in vitro by diamidines.
Kandpal M; Tekwani BL; Chauhan PM; Bhaduri AP
Life Sci; 1996; 59(7):PL75-80. PubMed ID: 8761349
[TBL] [Abstract][Full Text] [Related]
36. Characterization of RNA from Leishmania tropica and Leishmania d.donovani promastigotes.
Vedel M; Robert-Géro M
Mol Biochem Parasitol; 1987 May; 24(1):81-7. PubMed ID: 2441255
[TBL] [Abstract][Full Text] [Related]
37. Leishmania major and Leishmania tropica: I the in vitro effects of an immunomodulator, S2-Complex.
Al-Mulla Hummadi YM; Najim RA; Al-Bashir NM
Exp Parasitol; 2005 Sep; 111(1):47-54. PubMed ID: 15970286
[TBL] [Abstract][Full Text] [Related]
38. Uptake into leishmania donovani promastigotes and antileishmanial action of an organometallic complex derived from pentamidine.
Mbongo N; Loiseau PM; Lawrence F; Craciunescu DG; Robert-Gero M
Arzneimittelforschung; 1998 Aug; 48(8):850-5. PubMed ID: 9748715
[TBL] [Abstract][Full Text] [Related]
39. Hybrid molecules: growth inhibition of Leishmania donovani promastigotes by thiosemicarbazones of 3-carboxy-beta-carbolines.
Dodd RH; Ouannès C; Robert-Gèro M; Potier P
J Med Chem; 1989 Jun; 32(6):1272-6. PubMed ID: 2470903
[TBL] [Abstract][Full Text] [Related]
40. Metacyclogenesis of Leishmania spp: species-specific in vitro transformation, complement resistance, and cell surface carbohydrate and protein profiles.
Bandyopadhyay P; Ghosh DK; De A; Ghosh KN; Chaudhuri PP; Das P; Bhattacharya A
J Parasitol; 1991 Jun; 77(3):411-6. PubMed ID: 2040953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
